Phcogj.Com Potential Activity of Medicinal Plants As Pain Modulators
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
Index Vol. 12-15
353 INDEX VOL. 12-15 Die Stichworte des Sachregisters sind in der jeweiligen Sprache der einzelnen Beitrage aufgefiihrt. Les termes repris dans la Table des matieres sont donnes selon la langue dans laquelle l'ouvrage est ecrit. The references of the Subject Index are given in the language of the respective contribution. 14 AAG (Alpha-acid glycoprotein) 120 14 Adenosine 108 12 Abortion 151 12 Adenosine-phosphate 311 13 Abscisin 12, 46, 66 13 Adenosine-5'-phosphosulfate 148 14 Absorbierbarkeit 317 13 Adenosine triphosphate 358 14 Absorption 309, 350 15 S-Adenosylmethionine 261 13 Absorption of drugs 139 13 Adipaenin (Spasmolytin) 318 14 - 15 12 Adrenal atrophy 96 14 Absorptionsgeschwindigkeit 300, 306 14 - 163, 164 14 Absorptionsquote 324 13 Adrenal gland 362 14 ACAI (Anticorticocatabolic activity in 12 Adrenalin(e) 319 dex) 145 14 - 209, 210 12 Acalo 197 15 - 161 13 Aceclidine (3-Acetoxyquinuclidine) 307, 13 {i-Adrenergic blockers 119 308, 310, 311, 330, 332 13 Adrenergic-blocking activity 56 13 Acedapsone 193,195,197 14 O(-Adrenergic blocking drugs 36, 37, 43 13 Aceperone (Acetabutone) 121 14 {i-Adrenergic blocking drugs 38 12 Acepromazin (Plegizil) 200 14 Adrenergic drugs 90 15 Acetanilid 156 12 Adrenocorticosteroids 14, 30 15 Acetazolamide 219 12 Adrenocorticotropic hormone (ACTH) 13 Acetoacetyl-coenzyme A 258 16,30,155 12 Acetohexamide 16 14 - 149,153,163,165,167,171 15 1-Acetoxy-8-aminooctahydroindolizin 15 Adrenocorticotropin (ACTH) 216 (Slaframin) 168 14 Adrenosterone 153 13 4-Acetoxy-1-azabicyclo(3, 2, 2)-nonane 12 Adreson 252 -
The Use of Plants in the Traditional Management of Diabetes in Nigeria: Pharmacological and Toxicological Considerations
Journal of Ethnopharmacology 155 (2014) 857–924 Contents lists available at ScienceDirect Journal of Ethnopharmacology journal homepage: www.elsevier.com/locate/jep Review The use of plants in the traditional management of diabetes in Nigeria: Pharmacological and toxicological considerations Udoamaka F. Ezuruike n, Jose M. Prieto 1 Center for Pharmacognosy and Phytotherapy, Department of Pharmaceutical and Biological Chemistry, School of Pharmacy, University College London, 29-39 Brunswick Square, WC1N 1AX London, United Kingdom article info abstract Article history: Ethnopharmacological relevance: The prevalence of diabetes is on a steady increase worldwide and it is Received 15 November 2013 now identified as one of the main threats to human health in the 21st century. In Nigeria, the use of Received in revised form herbal medicine alone or alongside prescription drugs for its management is quite common. We hereby 26 May 2014 carry out a review of medicinal plants traditionally used for diabetes management in Nigeria. Based on Accepted 26 May 2014 the available evidence on the species' pharmacology and safety, we highlight ways in which their Available online 12 June 2014 therapeutic potential can be properly harnessed for possible integration into the country's healthcare Keywords: system. Diabetes Materials and methods: Ethnobotanical information was obtained from a literature search of electronic Nigeria databases such as Google Scholar, Pubmed and Scopus up to 2013 for publications on medicinal plants Ethnopharmacology used in diabetes management, in which the place of use and/or sample collection was identified as Herb–drug interactions Nigeria. ‘Diabetes’ and ‘Nigeria’ were used as keywords for the primary searches; and then ‘Plant name – WHO Traditional Medicine Strategy accepted or synonyms’, ‘Constituents’, ‘Drug interaction’ and/or ‘Toxicity’ for the secondary searches. -
M.Sc. CHEMISTRY
M.Sc. CHEMISTRY ANALYTICAL CHEMISTRY SPECIALISATION SYLLABUS OF III & IV SEMESTERS REVISED AS PER NEW (CB) SYLLABUS FOR STUDENTS ADMITTED FROM THE YEAR 2016 ONWARDS M.Sc. CHEMISTRY (ANALYTICAL CHEMISTRY SPECIALISATION) Syllabus for III and IV Semesters (for the batches admitted in academic year 2016 & later under CBCS pattern) [Under Restructured CBCS Scheme] Grand total marks and credits (all 4 semesters) 2400 marks – 96 credits (Approved in the P.G. BOS meeting held on 01-07-2017) Semester - III (ANALYTICAL CHEMISTRY) [Under CBCS Scheme] (for the batches admitted in academic year 2016 & later under CBCS pattern) Hrs/week Internal assessment Semester exam Total Credits CH(AC)301T (core) 4 20 marks 80 marks 100 marks 4 CH(AC)302T (core) 4 20 marks 80 marks 100 marks 4 CH(AC)303T (Elective) 4 20 marks 80 marks 100 marks 4 CH(AC)304T (Elective) 4 20 marks 80 marks 100 marks 4 CH(AC)351P (LAB-I) 9 100 marks 4 CH(AC)352P (LAB-II) 9 100 marks 4 Total 600 marks 24 Semester - IV (ANALYTICAL CHEMISTRY) Hrs/week Internal assessment Semester exam Total Credits CH(AC)401T (core) 4 20 marks 80 marks 100 marks 4 CH(AC)402T (core) 4 20 marks 80 marks 100 marks 4 CH(AC)403T (Elective) 4 20 marks 80 marks 100 marks 4 CH(AC)404T (Elective) 4 20 marks 80 marks 100 marks 4 CH(AC)451P (LAB-I) 9 100 marks 4 CH(AC)452P (LAB-II) 9 100 marks 4 Total 600 marks 24 Grand total marks and credits (all 4 semesters) 2400 marks - 96 credits M.Sc.ANALYTICAL CHEMISTRY Semester III Paper I :CH (AC) 301T: CORE : Sampling, Data handling, Classical and Atomic spectral methods -
Original Article Effect of GABA on Blood Pressure and Blood Dynamics of Anesthetic Rats
Int J Clin Exp Med 2015;8(8):14296-14302 www.ijcem.com /ISSN:1940-5901/IJCEM0008622 Original Article Effect of GABA on blood pressure and blood dynamics of anesthetic rats Pengju Ma1, Ting Li2, Fanceng Ji3, Haibo Wang4, Juntao Pang4 1Department of Anesthesiogy, Anqiu People’s Hospital, Anqiu 262100, China; 2Delivery Room, People’s Hospital of Anqiu, Anqiu 262100, China; 3Department of Anesthesiogy, Weifang People’s Hospital, Weifang 261041, China; 4Department of Critical Care Medicine of Weifang People’s Hospital, Weifang 261041, China Received March 31, 2015; Accepted August 13, 2015; Epub August 15, 2015; Published August 30, 2015 Abstract: Background: This study aimed to investigate GABA effects on blood pressure and blood dynamics of an- esthetic rats by observing spontaneously hypertensive rats under both anesthesia and waking state. Materials and methods: 72 male waking Wistar-Kyokos (WKY) rats and 72 male anesthetized spontaneously hypertensive (SHR) rats were randomly divided into control group and experimental group (N = 36 each). Rats were further divided into three subgroups (N = 12 each), which received 15 μmol GABA, 35 nmol muscimol, or 4 nmol dicentrine into uni- lateral paraventricular nucleus, respectively. Rats in the control group (WKY1) and experimental group (SHR1) were compared for the GABA effect on blood pressure (MAP), heart rate (HR), and arterial baroreceptor reflex function (BRS) changes under waking state. Anesthetic WKY rats (WKY2) and spontaneously hypertensive rats (SHR2) were compared for the GABA effect on those abovementioned indexes. Abdominal aorta mean arterial pressure, heart rate, and arterial baroreceptor reflex function changes were compared in all rats. Results: MAP, HR, and BRS were slightly lower in the rats under anesthetic state than in waking state before treatment (P < 0.05); they did not show significant changes between anesthetic and waking state, however, after treatment (P > 0.05). -
(12) United States Patent (10) Patent No.: US 8,980,319 B2 Park Et Al
US00898O319B2 (12) United States Patent (10) Patent No.: US 8,980,319 B2 Park et al. (45) Date of Patent: *Mar. 17, 2015 (54) METHODS OF PRODUCING STABILIZED A613 L/445 (2006.01) SOLID DOSAGE PHARMACEUTICAL A613 L/47 (2006.01) COMPOSITIONS CONTAINING A6II 45/06 (2006.01) MORPHINANS A63/67 (2006.01) (52) U.S. Cl. (71) Applicant: Mallinckrodt LLC, Hazelwood, MO CPC ............. A6 IK3I/485 (2013.01); A61 K9/1652 (US) (2013.01); A61 K9/2031 (2013.01); A61 K 9/2081 (2013.01); A61 K9/2086 (2013.01); (72) Inventors: Jae Han Park, Olivette, MO (US); A6IK9/2095 (2013.01); A61 K9/5042 Tiffani Eisenhauer, Columbia, IL (US); (2013.01); A61 K3I/4355 (2013.01); A61 K Spainty,S.Isna Gupta, F11llsborough, 31/4375A6 (2013.01); IK3I/445 gets (2013.01); it' A6 (2013.01); IK3I/47 Stephen Overholt, Middlesex, NJ (US) (2013.01); A61K 45/06 (2013.01); A61 K 9/2013 (2013.01); A61 K9/209 (2013.01); (73) Assignee: Mallinckrodt LLC, Hazelwood, MO A6 IK3I/167 (2013.01) (US) USPC ........... 424/472: 424/465; 424/468; 424/490; c - r - 514/282; 514/289 (*) Notice: Subject to any disclaimer, the term of this (58) Field of Classification Search patent is extended or adjusted under 35 N U.S.C. 154(b)b) by 0 daysyS. Seeone application file for complete search history. This patent is Subject to a terminal dis claimer. (56) References Cited (21) Appl. No.: 14/092.375 U.S. PATENT DOCUMENTS (22) Filed: Nov. 27, 2013 2008, 0026052 A1 ck 1/2008 Schoenhard ................. -
Chapter Two Biomimetic Partial Synthesis Of
CHAPTER TWO BIOMIMETIC PARTIAL SYNTHESIS OF VALPARICINE AND APPARICINE 2.1 Introduction 2.1.1 Alkaloids of Kopsia arborea A total of 62 alkaloids were isolated from the stem-bark and leaves of Kopsia arborea of which 25 are new alkaloids. Among the alkaloids isolated are valparicine (28),26,27 pericine (31),26,28,29 pericidine (32),30,31 arbophylline (33),32 arboricine (34),30,33 arboricinine (35),30,33 arboflorine (36),30,34 arboloscine (37),30,31 and mersicarpine (38).35 14 The compounds of interest to this research are valparicine (28) and pericine (31). Valparicine (28) was isolated from the stem-bark extract of K. arborea in trace amount. It represents the first member of the pericine-type alkaloids, characterized by a 16-22 exocyclic double bond, in which bond-formation has occurred between C-3 and C-7.26 Preliminary tests indicated that valparicine (28) showed strong cytotoxic effects −1 against human KB cells (IC50 < 5 μgmL ). Valparicine (28) was obtained as a colorless oil, with [α]D −40 (c 0.22, CHCl3). The UV spectrum (228 and 297 nm) indicated the presence of an unsubstituted indolenine chromophore. The EIMS of 28 showed a molecular ion at m/z 276, which 13 analyzed for C19H20N2, differing from pericine (31) by loss of two hydrogens. The C NMR spectrum gave a total of 19 carbon resonances (one methyl, five methylenes, seven methines, and six quaternary carbons) in agreement with the molecular formula. In addition to the six carbon resonances readily attributable to the aromatic moiety, and the imine resonance at δC 186.4, two other downfield quaternary resonances were observed at δC 139.2 and 144.6. -
Microgram Journal, Vol 3, Number 2
MICROGRAM Laboratory Operations Division Office Of Science And Drug Abuse Prevention BUREAU OF NARCOTICS & DANGEROUS DRUGS / U.S. DEPARTMENT OF JUSTICE / WASHINGTION, D.C. 20537 Vol.III, No. 2 March-April, 1970 STP (4-Methyl-2,5-dimethoxyamphetamine) hydrochloride was found coating the inside of capsules sent to BNDDfrom Germany. The capsules were clear, hard gelatin, standard shape size No. o. Average weight was 114 milligrams. Each capsule had a white crystalline coating on inner surface of capsule body. Apparently a measu~ed amount of solution had been placedin the cap·sule body, after which it was rotated to spread the solution on the inner surface. The substance contained 8. 7 milli grams STP (DOM)HCl per ca·psule. · These were the first STP capsules of this type seen by our laboratory. A few years ago, capsules were ob tained in the U.S. similarly coated with LSD. STP (Free Base) on laboratory filter paper, also from Germany, was seen for the first time in our laboratory. The STP spots, containing approxi mately 8 miliigrams STP base each, were 5/8 to 3/4 inch in diameter. The paper was 1\ inches square. Phencyclidine (Free Base) was recently analyzed on parsley leaves. Called "Angel DUst, 11 the phencyclidine on two samples of leaves was 2.6% and 3.6%. Approximately thirty pounds of 94% pure powder was also analyzed. (For identification of phencyclidine base, see Microgram, II, 1, p.3 (Jan 1969). IMITATIONSof well-known drug products are examined frequently in our Special Testing and Research Laboratory. Many of these are well made preparations and closely resemble the imitated product. -
Nové Psychoaktívne Látky Rastlinného Pôvodu Na Drogovej Scéne
Prehľadové články 149 Nové psychoaktívne látky rastlinného pôvodu na drogovej scéne MUDr. Mária Martinove, ml. CPLDZ OLÚP, n. o., Predná Hora FZaSP TRUNI, Trnava Na drogovej scéne dochádza naďalej k vzniku a následne k užívaniu nových psychoaktívnych látok (NPL) nielen syntetického, ale aj rastlinného pôvodu. V súčasnosti k najčastejšie sa vyskytujúcim novým rastlinným drogám patrí khat, kratom a šalvia divotvorná. Majú celosvetový prienik na drogový trh a hlavnou cestou ich šírenia je internet. Kľúčové slová: nové prírodné látky, khat, kratom, šalvia divotvorná. New psychoactive plant-based substances on the drug scene On the drug scene there still continues rise and use of new psychoactive substances (NPS), not only synthetic substances but also plant- -based substances. Currently, the most commonly occurring plant-based new drugs include khat, kratom and salvia divinorum. They have global effect on the drug market and the main way of their distribution is the Internet. Key words: new plant-based substances, khat, kratom, salvia divinorum. Psychiatr. prax; 2014; 15(4): 149–152 Úvod vých krajín), Ázia (7 nových krajín) a Afrika (6 to oblastiach. Psychoaktívne účinky vyplývajú Súčasný drogový trh nám okrem iného po- nových krajín) (17). z uvoľnenia katinónu a katínu pri žuvaní listov (15). núka nové psychoaktívne látky (NPL), ktoré sú Khat ako ker sa dostal do povedomia nové z hľadiska výskytu na drogovej scéne a roz- Celosvetový prienik NPL Európanom už koncom 18. storočia a v 19. sto- šírené už nielen v radoch rekreačných užívateľov rastlinného pôvodu ročí, a jeho aktívne zložky z rastlín boli izolované drog, ale aj u problémových užívateľov drog. Dvadsaťtri krajín zo všetkých regió- v 19. -
An in Silico Study of the Ligand Binding to Human Cytochrome P450 2D6
AN IN SILICO STUDY OF THE LIGAND BINDING TO HUMAN CYTOCHROME P450 2D6 Sui-Lin Mo (Doctor of Philosophy) Discipline of Chinese Medicine School of Health Sciences RMIT University, Victoria, Australia January 2011 i Declaration I hereby declare that this submission is my own work and to the best of my knowledge it contains no materials previously published or written by another person, or substantial proportions of material which have been accepted for the award of any other degree or diploma at RMIT university or any other educational institution, except where due acknowledgment is made in the thesis. Any contribution made to the research by others, with whom I have worked at RMIT university or elsewhere, is explicitly acknowledged in the thesis. I also declare that the intellectual content of this thesis is the product of my own work, except to the extent that assistance from others in the project‘s design and conception or in style, presentation and linguistic expression is acknowledged. PhD Candidate: Sui-Lin Mo Date: January 2011 ii Acknowledgements I would like to take this opportunity to express my gratitude to my supervisor, Professor Shu-Feng Zhou, for his excellent supervision. I thank him for his kindness, encouragement, patience, enthusiasm, ideas, and comments and for the opportunity that he has given me. I thank my co-supervisor, A/Prof. Chun-Guang Li, for his valuable support, suggestions, comments, which have contributed towards the success of this thesis. I express my great respect to Prof. Min Huang, Dean of School of Pharmaceutical Sciences at Sun Yat-sen University in P.R.China, for his valuable support. -
Alkaloids Used As Medicines: Structural Phytochemistry Meets Biodiversity—An Update and Forward Look
molecules Review Alkaloids Used as Medicines: Structural Phytochemistry Meets Biodiversity—An Update and Forward Look Michael Heinrich 1,2,* , Jeffrey Mah 1 and Vafa Amirkia 1 1 Research Group ‘Pharmacognosy and Phytotherapy’, UCL School of Pharmacy, University of London, 29–39 Brunswick Sq., London WC1N 1AX, UK; [email protected] (J.M.); [email protected] (V.A.) 2 Graduate Institute of Integrated Medicine, College of Chinese Medicine, and Chinese Medicine Research Center, China Medical University, No. 100, Section 1, Jingmao Road, Beitun District, Taichung 406040, Taiwan * Correspondence: [email protected]; Tel.: +44-20-7753-5844 Abstract: Selecting candidates for drug developments using computational design and empirical rules has resulted in a broad discussion about their success. In a previous study, we had shown that a species’ abundance [as expressed by the GBIF (Global Biodiversity Information Facility)] dataset is a core determinant for the development of a natural product into a medicine. Our overarching aim is to understand the unique requirements for natural product-based drug development. Web of Science was queried for research on alkaloids in combination with plant systematics/taxonomy. All alkaloids containing species demonstrated an average increase of 8.66 in GBIF occurrences between 2014 and 2020. Medicinal Species with alkaloids show higher abundance compared to non-medicinal alkaloids, often linked also to cultivation. Alkaloids with high biodiversity are often simple alkaloids found in multiple species with the presence of ’driver species‘ and are more likely to be included in early-stage drug development compared to ‘rare’ alkaloids. Similarly, the success of an alkaloid Citation: Heinrich, M.; Mah, J.; Amirkia, V. -
The Main Tea Eta a El Mattitauli Mali Malta
THE MAIN TEA ETA USA 20180169172A1EL MATTITAULI MALI MALTA ( 19 ) United States (12 ) Patent Application Publication ( 10) Pub . No. : US 2018 /0169172 A1 Kariman (43 ) Pub . Date : Jun . 21 , 2018 ( 54 ) COMPOUND AND METHOD FOR A61K 31/ 437 ( 2006 .01 ) REDUCING APPETITE , FATIGUE AND PAIN A61K 9 / 48 (2006 .01 ) (52 ) U . S . CI. (71 ) Applicant : Alexander Kariman , Rockville , MD CPC . .. .. .. .. A61K 36 / 74 (2013 .01 ) ; A61K 9 / 4825 (US ) (2013 . 01 ) ; A61K 31/ 437 ( 2013 . 01 ) ; A61K ( 72 ) Inventor: Alexander Kariman , Rockville , MD 31/ 4375 (2013 .01 ) (US ) ( 57 ) ABSTRACT The disclosed invention generally relates to pharmaceutical (21 ) Appl . No. : 15 /898 , 232 and nutraceutical compounds and methods for reducing appetite , muscle fatigue and spasticity , enhancing athletic ( 22 ) Filed : Feb . 16 , 2018 performance , and treating pain associated with cancer, trauma , medical procedure , and neurological diseases and Publication Classification disorders in subjects in need thereof. The disclosed inven ( 51 ) Int. Ci. tion further relates to Kratom compounds where said com A61K 36 / 74 ( 2006 .01 ) pound contains at least some pharmacologically inactive A61K 31/ 4375 ( 2006 .01 ) component. pronuPatent Applicationolan Publication manu saJun . decor21, 2018 deSheet les 1 of 5 US 2018 /0169172 A1 reta Mitragynine 7 -OM - nitragynine *** * *momoda W . 00 . Paynantheine Speciogynine **** * * * ! 1000 co Speclociliatine Corynartheidine Figure 1 Patent Application Publication Jun . 21, 2018 Sheet 2 of 5 US 2018 /0169172 A1 -
Dicentrine Production from a Hairy Roots Culture of Stephania Suberosa
Dicentrine Production from a Hairy Roots Culture of Stephania suberosa Waraporn Putalun*, Gorawit Yusakul, and Denpong Patanasethanont Faculty of Pharmaceutical Sciences, Khon Kaen University, Khon Kaen, 40002, Thailand. Fax: +66-43-2 02-3 79. E-mail: [email protected] * Author for correspondence and reprint requests Z. Naturforsch. 64 c, 692 – 696 (2009); received June 8/July 2, 2009 A hairy roots culture of Stephania suberosa was established using Agrobacterium rhizo- genes ATCC15834. The production of dicentrine was found to be (8.92 ± 0.07) mg/g dry wt on day 35 of culture. Effects of sucrose content, tyrosine, and medium strength on growth and dicentrine production of S. suberosa were investigated. 6% (w/v) sucrose was an op- timum content for the growth and dicentrine accumulation in S. suberosa hairy roots. The utilization of a precursor from tyrosine feeding enhanced the dicentrine production. The medium with 1.0 mM of tyrosine had the highest effect on dicentrine accumulation in hairy roots at day 40 of culture [(14.73 ± 0.47) mg/g dry wt]. In addition, ¼ Murashige and Skoog medium was suitable for biomass and dicentrine production in hairy roots. This culture sys- tem has a potential to produce dicentrine from hairy roots of S. suberosa. Key words: Dicentrine, Hairy Roots, Stephania suberosa Introduction achieved in S. suberosa tuberous roots (Patra et al., 1986; Sriprang et al., 2006). Therefore, hairy Stephania suberosa Forman (Menispermaceae) roots cultures of S. suberosa are necessary for the is a medicinal plant which has been used in Thai production of biological compounds. It is known traditional medicine for the treatment of hyper- that many factors could affect the secondary me- tension.